Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
California Neuropsychopharmacology Clinical Research Instit
mi
from
San Diego, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
California Neuropsychopharmacology Clinical Research Instit
mi
from
San Diego, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Collaborative Neuroscience Network, INC
mi
from
Torrance, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
MCB Clinical Research Centers-Colorado Springs
mi
from
Colorado Springs, CO
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
MCB Clinical Research Centers-Colorado Springs
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Accurate Clinical Trials
mi
from
Kissimmee, FL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Accurate Clinical Trials
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
University of South Florida Institute - Tampa
mi
from
Tampa, FL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
University of South Florida Institute - Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Janus Center for Psychiatric Research
mi
from
West Palm Beach, FL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Janus Center for Psychiatric Research
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Institute for Behavioral Medicine
mi
from
Smyrna, GA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
American Medical Research, Inc.
mi
from
Oak Brook, IL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
American Medical Research, Inc.
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Booker, J. Gary, MD. APMC
mi
from
Shreveport, LA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Booker, J. Gary, MD. APMC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Sheppard Pratt Health System
mi
from
Baltimore, MD
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Capitol Clinical Research
mi
from
Rockville, MD
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Capitol Clinical Research
mi
from
Rockville, MD
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Precise Research Centers
mi
from
Flowood, MS
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Precise Research Centers
mi
from
Flowood, MS
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Midwest Research Group
mi
from
St. Charles, MO
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
CRI Worldwide, LLC
mi
from
Willingboro, NJ
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
CRI Worldwide, LLC
mi
from
Willingboro, NJ
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Albuquerque Neuroscience Inc.
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Social Psychiatry Research Institute
mi
from
Brooklyn, NY
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Social Psychiatry Research Institute
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Neurobehavioral Research, Inc.
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Medical & Behavioral Health Research
mi
from
New York, NY
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Medical & Behavioral Health Research
mi
from
New York, NY
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Village Clinical Research Inc.
mi
from
New York, NY
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Village Clinical Research Inc.
mi
from
New York, NY
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Richard H. Weisler & Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Zarzar Psychiatric Associates, PLLC
mi
from
Raleigh, NC
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Zarzar Psychiatric Associates, PLLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Quest Therapeutics
mi
from
Avon Lake, OH
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Quest Therapeutics
mi
from
Avon Lake, OH
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Psychiatric Professional Services, Inc.
mi
from
Cincinnati, OH
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Psychiatric Professional Services, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
MetroHealth System
mi
from
Cleveland, OH
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
MetroHealth System
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Mood Disorders Program-UHCMC
mi
from
Cleveland, OH
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Mood Disorders Program-UHCMC
mi
from
Cleveland, OH
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Summit Research Network (Oregon) Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Lehigh Valley Hospital
mi
from
Allentown, PA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Lehigh Valley Hospital
mi
from
Allentown, PA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
FutureSearch Clinical Trials LP
mi
from
Austin, TX
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
FutureSearch Trials
mi
from
Dallas, TX
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
FutureSearch Trials
mi
from
Dallas, TX
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Pillar Clinical Research, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Red Oak Psychiatry Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Wharton Research Center
mi
from
Wharton, TX
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Wharton Research Center
mi
from
Wharton, TX
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Clinical Innovations, Inc
mi
from
Costa Mesa, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Clinical Innovations, Inc
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Clinical Innovations, Inc.
mi
from
Santa Ana, CA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Clinical Innovations, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
University of Colorado
mi
from
Aurora, CO
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Florida Clinical Research Center, LLC
mi
from
Fruitland Park, FL
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Florida Clinical Research Center, LLC
mi
from
Fruitland Park, FL
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Northwest Behavioral Research Center
mi
from
Rosewekk, GA
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Northwest Behavioral Research Center
mi
from
Rosewekk, GA
Click here to add this to my saved trials
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated:  3/15/2016
Clinical Research Group Edmonton
mi
from
Edmonton,
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
Status: Enrolling
Updated: 3/15/2016
Clinical Research Group Edmonton
mi
from
Edmonton,
Click here to add this to my saved trials
Sleep to Activate Mood Promotion
Sleep to Activate Mood Promotion- Intervention
Status: Enrolling
Updated:  3/15/2016
University of Michigan
mi
from
Ann Arbor, MI
Sleep to Activate Mood Promotion
Sleep to Activate Mood Promotion- Intervention
Status: Enrolling
Updated: 3/15/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Pioglitazone for the Treatment of Bipolar Depression
Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression
Status: Enrolling
Updated:  3/16/2016
University Hospitals Case Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Pioglitazone for the Treatment of Bipolar Depression
Double-Blind, Placebo-Controlled Trial of Pioglitazone for Bipolar Depression
Status: Enrolling
Updated: 3/16/2016
University Hospitals Case Medical Center - Mood Disorders Program
mi
from
Cleveland, OH
Click here to add this to my saved trials